610 related articles for article (PubMed ID: 11115327)
1. Ketamine-induced deficits in auditory and visual context-dependent processing in healthy volunteers: implications for models of cognitive deficits in schizophrenia.
Umbricht D; Schmid L; Koller R; Vollenweider FX; Hell D; Javitt DC
Arch Gen Psychiatry; 2000 Dec; 57(12):1139-47. PubMed ID: 11115327
[TBL] [Abstract][Full Text] [Related]
2. Effects of the 5-HT2A agonist psilocybin on mismatch negativity generation and AX-continuous performance task: implications for the neuropharmacology of cognitive deficits in schizophrenia.
Umbricht D; Vollenweider FX; Schmid L; Grübel C; Skrabo A; Huber T; Koller R
Neuropsychopharmacology; 2003 Jan; 28(1):170-81. PubMed ID: 12496954
[TBL] [Abstract][Full Text] [Related]
3. Deficits in auditory and visual context-dependent processing in schizophrenia: defining the pattern.
Javitt DC; Shelley AM; Silipo G; Lieberman JA
Arch Gen Psychiatry; 2000 Dec; 57(12):1131-7. PubMed ID: 11115326
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of cerebral type 1 cannabinoid receptors is associated with impaired auditory mismatch negativity generation in the ketamine model of schizophrenia.
Roser P; Haussleiter IS; Chong HJ; Maier C; Kawohl W; Norra C; Juckel G
Psychopharmacology (Berl); 2011 Dec; 218(4):611-20. PubMed ID: 21590281
[TBL] [Abstract][Full Text] [Related]
5. Mismatch negativity generation in the human 5HT2A agonist and NMDA antagonist model of psychosis.
Heekeren K; Daumann J; Neukirch A; Stock C; Kawohl W; Norra C; Waberski TD; Gouzoulis-Mayfrank E
Psychopharmacology (Berl); 2008 Jul; 199(1):77-88. PubMed ID: 18488201
[TBL] [Abstract][Full Text] [Related]
6. Glutamatergic modulation of auditory information processing in the human brain.
Gunduz-Bruce H; Reinhart RM; Roach BJ; Gueorguieva R; Oliver S; D'Souza DC; Ford JM; Krystal JH; Mathalon DH
Biol Psychiatry; 2012 Jun; 71(11):969-77. PubMed ID: 22036036
[TBL] [Abstract][Full Text] [Related]
7. Role of cortical N-methyl-D-aspartate receptors in auditory sensory memory and mismatch negativity generation: implications for schizophrenia.
Javitt DC; Steinschneider M; Schroeder CE; Arezzo JC
Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11962-7. PubMed ID: 8876245
[TBL] [Abstract][Full Text] [Related]
8. Nicotine fails to attenuate ketamine-induced cognitive deficits and negative and positive symptoms in humans: implications for schizophrenia.
D'Souza DC; Ahn K; Bhakta S; Elander J; Singh N; Nadim H; Jatlow P; Suckow RF; Pittman B; Ranganathan M
Biol Psychiatry; 2012 Nov; 72(9):785-94. PubMed ID: 22717030
[TBL] [Abstract][Full Text] [Related]
9. Mismatch negativity encoding of prediction errors predicts S-ketamine-induced cognitive impairments.
Schmidt A; Bachmann R; Kometer M; Csomor PA; Stephan KE; Seifritz E; Vollenweider FX
Neuropsychopharmacology; 2012 Mar; 37(4):865-75. PubMed ID: 22030715
[TBL] [Abstract][Full Text] [Related]
10. Mismatch negativity predicts psychotic experiences induced by NMDA receptor antagonist in healthy volunteers.
Umbricht D; Koller R; Vollenweider FX; Schmid L
Biol Psychiatry; 2002 Mar; 51(5):400-6. PubMed ID: 11904134
[TBL] [Abstract][Full Text] [Related]
11. The effects of ketamine on the mismatch negativity (MMN) in humans - A meta-analysis.
Rosburg T; Kreitschmann-Andermahr I
Clin Neurophysiol; 2016 Feb; 127(2):1387-1394. PubMed ID: 26699665
[TBL] [Abstract][Full Text] [Related]
12. Interactive effects of an N-methyl-d-aspartate receptor antagonist and a nicotinic acetylcholine receptor agonist on mismatch negativity: Implications for schizophrenia.
Hamilton HK; D'Souza DC; Ford JM; Roach BJ; Kort NS; Ahn KH; Bhakta S; Ranganathan M; Mathalon DH
Schizophr Res; 2018 Jan; 191():87-94. PubMed ID: 28711472
[TBL] [Abstract][Full Text] [Related]
13. Rodent Mismatch Negativity/theta Neuro-Oscillatory Response as a Translational Neurophysiological Biomarker for N-Methyl-D-Aspartate Receptor-Based New Treatment Development in Schizophrenia.
Lee M; Balla A; Sershen H; Sehatpour P; Lakatos P; Javitt DC
Neuropsychopharmacology; 2018 Feb; 43(3):571-582. PubMed ID: 28816240
[TBL] [Abstract][Full Text] [Related]
14. Effects of Acute Ketamine Infusion on Visual Working Memory: Event-Related Potentials.
Koychev I; William Deakin JF; El-Deredy W; Haenschel C
Biol Psychiatry Cogn Neurosci Neuroimaging; 2017 Apr; 2(3):253-262. PubMed ID: 29528296
[TBL] [Abstract][Full Text] [Related]
15. Role of N-Methyl-D-Aspartate Receptors in Action-Based Predictive Coding Deficits in Schizophrenia.
Kort NS; Ford JM; Roach BJ; Gunduz-Bruce H; Krystal JH; Jaeger J; Reinhart RM; Mathalon DH
Biol Psychiatry; 2017 Mar; 81(6):514-524. PubMed ID: 27647218
[TBL] [Abstract][Full Text] [Related]
16. Glutamatergic deficit and schizophrenia-like negative symptoms: new evidence from ketamine-induced mismatch negativity alterations in healthy male humans.
Thiebes S; Leicht G; Curic S; Steinmann S; Polomac N; Andreou C; Eichler I; Eichler L; Zöllner C; Gallinat J; Hanganu-Opatz I; Mulert C
J Psychiatry Neurosci; 2017 Jun; 42(4):273-283. PubMed ID: 28556775
[TBL] [Abstract][Full Text] [Related]
17. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses.
Krystal JH; Karper LP; Seibyl JP; Freeman GK; Delaney R; Bremner JD; Heninger GR; Bowers MB; Charney DS
Arch Gen Psychiatry; 1994 Mar; 51(3):199-214. PubMed ID: 8122957
[TBL] [Abstract][Full Text] [Related]
18. Early sensory contributions to contextual encoding deficits in schizophrenia.
Dias EC; Butler PD; Hoptman MJ; Javitt DC
Arch Gen Psychiatry; 2011 Jul; 68(7):654-64. PubMed ID: 21383251
[TBL] [Abstract][Full Text] [Related]
19. Effect of ketamine on the neuromagnetic mismatch field in healthy humans.
Kreitschmann-Andermahr I; Rosburg T; Demme U; Gaser E; Nowak H; Sauer H
Brain Res Cogn Brain Res; 2001 Aug; 12(1):109-16. PubMed ID: 11489614
[TBL] [Abstract][Full Text] [Related]
20. Selective Prefrontal Disinhibition in a Roving Auditory Oddball Paradigm Under N-Methyl-D-Aspartate Receptor Blockade.
Rosch RE; Auksztulewicz R; Leung PD; Friston KJ; Baldeweg T
Biol Psychiatry Cogn Neurosci Neuroimaging; 2019 Feb; 4(2):140-150. PubMed ID: 30115499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
